The Bacterial Vaccines Section focuses on the production of vaccines targeting major bacterial diseases of livestock. It integrates modern biotechnology, aseptic processing, and advanced fermentation systems to ensure consistent quality and potency.
The section operates under Good Manufacturing Practices (GMP) and national regulatory standards. It is supported by dedicated microbiology, formulation, and quality assurance teams.
The section is equipped with modern fermentation units, laminar airflow cabinets, clean rooms, sterile filtration systems, and lyophilization support facilities. All processes are monitored under validated protocols ensuring consistency and compliance.
The team actively engages in process optimization, vaccine improvement studies, and pilot trials of new bacterial antigens. Collaboration with national research institutes strengthens innovation and continuous quality enhancement.
Each batch of vaccine produced undergoes safety, sterility, purity, and potency tests in compliance with national veterinary biological standards. The section works closely with the Quality Control and Quality Assurance divisions to ensure excellence.